SBDS Antikörper (C-Term)
Kurzübersicht für SBDS Antikörper (C-Term) (ABIN629754)
Target
Alle SBDS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- SBDS antibody was raised against the C terminal of SBDS
-
Aufreinigung
- Purified
-
Immunogen
- SBDS antibody was raised using the C terminal of SBDS corresponding to a region with amino acids DYGQQLEIVCLIDPGCFREIDELIKKETKGKGSLEVLNLKDVEEGDEKFE
-
-
-
-
Applikationshinweise
-
WB: 1.25 µg/mL, IHC: 4-8 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
SBDS Blocking Peptide, (ABIN937623), is also available for use as a blocking control in assays to test for specificity of this SBDS antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of SBDS antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- SBDS (Shwachman-Bodian-Diamond Syndrome (SBDS))
-
Andere Bezeichnung
- SBDS
-
Hintergrund
- SBDS is a member of a highly conserved protein family that exists from archaea to vertebrates and plants. The protein may function in RNA metabolism. Mutations within its gene are associated with Shwachman-Bodian-Diamond syndrome.
-
Molekulargewicht
- 28 kDa (MW of target protein)
-
Pathways
- Ribonucleoprotein Complex Subunit Organization, Ribosome Assembly
Target
-